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Acute oral consumption of various natural inhibitors of amylase (bean and hibiscus extracts) and sucrase 
(L-arabinose) reduce absorption of starch and sucrose respectively in rats and pigs measured by lessened 
appearance of circulating glucose levels. The present subchronic study was designed to determine whether these 
selected inhibitors of gastrointestinal starch and sucrose absorption (so-called “carb blockers”) remain effective 
with continued use and to assess their metabolic influences after prolonged intake. Sprague-Dawley rats were 
gavaged twice daily over nine weeks with either water or an equal volume of water containing a formula that 
included bean and hibiscus extracts and L-arabinose. To estimate CHO absorption, control and treated 
Sprague-Dawley rats were gavaged with either water alone or an equal volume of water containing glucose, rice 
starch, sucrose, or combined rice starch and sucrose. Circulating glucose was measured at timed intervals over 
four hours. The ability to decrease starch and sucrose absorption use. No toxic effects (hepatic, renal, 
hematologic) were evident. Blood chemistries revealed significantly lower circulating glucose levels and a trend 
toward decreased HbA1C in the nondiabetic rats receiving the natural formulation compared to control. 
Subchronic administration of enzyme inhibitors was also associated with many metabolic changes including 
lowered systolic blood pressure and altered fluid-electrolyte balance. We postulate that proper intake of natural 
amylase and sucrase inhibitors may be useful in the prevention and treatment of many chronic disorders 
associated with perturbations in glucose-insulin homeostasis secondary to the rapid absorption of refined CHO. 
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1.  INTRODUCTION 
Excess consumption of refined, rapidly absorbed 
carbohydrates (CHO) contributes to insulin resistance 
[1-3]. In turn, insulin resistance is associated with 
many troublesome, age-related perturbations 
including hypertension, dyslipidemias, diabetes, 
obesity and even premature aging [4-7]. Yudkin and 
associates [8-14] were among the first to promote the 
concept that table sugar was responsible in many cases 
for obesity and connected dysfunctions in insulin 
metabolism with many other aspects of the metabolic 
syndrome. While aging is associated with insulin 
resistance [15-17], insulin resistance may hasten the 
aging process – a vicious circle [4,5,7]. Suffice it to say, 
the most common experimental means to lengthen life 
span, caloric restriction, appears to work, at least in 
part, through its beneficial effects on the insulin system 
[18]. 
The many who believe that the excessive intake of 
refined CHO plays a major role in the development of 
insulin resistance have sought practical means to 
overcome this situation [19]. First, planned diets with 
low proportions of refined CHO have become popular. 
However, these diets do not satisfy everyone, and 
many concerns exist over the replacement of CHO 
with fats [20,21]. Second, refined CHO with their rapid 
absorption (high glycemic index) are more prone to 
cause insulin resistance than complex carbohydrates 
with slower absorption (low glycemic index). Addition 
of soluble fiber to the diet can slow absorption of 
refined CHO, thus lowering the glycemic indices of 
foods and overcoming or ameliorating many of the 
adverse reactions resulting from increased refined 
CHO ingestion [22,23]. A third choice involves the use 
of natural dietary supplements that block and slow 
CHO absorption in the gastrointestinal tract. 
The two primary purposes of the present 
investigation were (1) to determine whether selected 
inhibitors of gastrointestinal starch and sucrose 
absorption (carb blockers) remain effective with 
continued use and (2) to assess their metabolic effects 
after prolonged intake.  
2.  METHODS AND PROCEDURES 
Animals: 
  The Animal Welfare Board at Georgetown 
University Medical Center approved this protocol for 
investigation. Sixteen Sprague-Dawley rats were Int. J. Med. Sci. 2007, 4 
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obtained from Taconic Laboratories (Germantown, 
NY). Rats ate regular rat chow, drank water ad libitum, 
and were maintained in a facility with constant 
temperature and a 12 hour light-dark phase. Adult rats 
weighed between 402-558 grams at the start of the 
study.  
Protocols: 
Rats were gavaged twice daily with one gram (a 
total of two grams) of a formula containing various 
CHO blockers in four ml of water per day for nine 
weeks (test) or four ml of water alone (control) for nine 
weeks. There were eight rats in each group. In the fifth 
week, the regular drinking water was replaced with a 
10% w/v sucrose solution. Systolic blood pressure 
(SBP) and body weight (BW) were measured weekly.  
Ingredients:  
The individual test ingredients as well as the 
formulation containing carb blockers were obtained 
from Advocare International, Carrollton, Texas1. The 
formulation was composed of w/w: dry bean extract 
(seed - Phaseolus vulgaris) 19%, hibiscus extract (flower 
- Hibiscus sabdariffa) 31%, L-arabinose 31%, gymnema 
extract ((leaf - Gymnema sylvestre) 12%, green tea 
extract leaf - (Camellia sinensis) 6%, and apple extract 
(fruit - Malus sylvestris) 1% plus the addition of 
Lactobacillus acidophilus and Bifidobacterium bifidum. 
Carbohydrate Tolerance Tests:  
After baseline blood was drawn, rats received 
either a gavage of two ml of water alone or two g rice 
starch, sucrose, glucose, or combined rice starch and 
sucrose in two ml of water. A drop of blood was 
obtained from the tail at baseline (time 0), 0.5 hour, 1 
hour, 2 hours, 3 hours and 4 hours for glucose 
determination. Overall, less than 0.5 ml of blood was 
obtained at one testing. Glucose was estimated using 
commercial glucose strips (Lifescan, One Touch Ultra, 
Melitas, CA).  
Miscellaneous Measurements 
SBP: SBP was measured by tail plethysmography 
using an instrument from Narco Biosciences (Houston, 
TX). This assay provided an indirect measure of SBP in 
conscious, slightly warmed rats [24]. In all studies, rats 
were allowed free access to their diet and water until 
SBP readings were obtained between 13.00 h and 17.00 
h. Readings on individual rats were taken 0.5-1 minute 
apart. To be accepted, SBP measurements on a given 
rat had to be virtually stable for at least three 
consecutive readings. In all studies, weekly readings 
were recorded. 
BW: BW was estimated by routine scale 
measurements. 
Blood Chemistries: Blood for chemical analysis 
was obtained at the end of the chronic protocol 
following removal of food four hours earlier. 
Biochemical analyses were performed by routine 
clinical procedures. 
                                                 
1 Carb-Ease, Advocare International, Carrollton, TX 
Statistical Analyses 
Results are presented as mean + SEM. SBP and 
BW were examined by 2-way analyses of variance (one 
factor being group and the second factor being time of 
examination). Where a significant effect of regimen 
was detected by repeated measures ANOVA (p<0.05), 
the Dunnett t test was used to establish which 
differences between means reached statistical 
significance [25]. When the data from two columns of 
data were analyzed at a single time point, Student’s t 
test was used. Statistical significance was set at a p < 
0.05. 
3.  RESULTS 
  The changes in body weight over the course of 
nine weeks were followed in eight rats gavaged daily 
with water (control) and eight rats gavaged daily with 
two grams of the formula containing carb blockers 
dissolved in a similar volume of water (test) (Fig. 1). 
The test group gained 46.5 g + 97.7 (SEM)(10.4%) and 
the control group gained 68.3g + 11.0 (SEM)(14.9%) of 
body weight by the end of the nine weeks. The 
differences were not statistically significant (p=0.12). 
SBP began to rise in the sixth week in the control rats, 
but decreased in the test rats after the fifth week (Fig. 
2). The differences appeared after both groups were 
challenged with 10% v/v sucrose solution instead of 
regular drinking water. The differences in SBP values 
were statistically significant between the control and 
test groups over the last four weeks of study. 
 
Fig. 1. The changes in body weight after daily challenges with 
water or two grams of the novel formulation dissolved in a 
similar volume of water is depicted. Mean + SEM shown for 
eight rats in each group. All rats drank a solution of 10% w/v 
sucrose in place of water from week 5 on 
 
  Between the seventh and ninth weeks of the 
subchronic study, the rats receiving the formula 
containing a variety of natural ingredients reputed to 
influence CHO absorption were individually Int. J. Med. Sci. 2007, 4 
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challenged with rice starch (Fig. 3), sucrose (Fig. 4), 
glucose (Fig. 5), or a combination of sucrose and rice 
starch (Fig. 6) in the same manner as in the previous 
acute studies [26]. In the rats receiving the formula for 
7-9 weeks, the appearance of blood glucose after the 
rice starch challenge was significantly lower, slightly 
more than one -half compared to control (Fig. 3). The 
area under the curve for the test rats was 61.0% of that 
for the control rats. Similarly, the appearance of 
circulating glucose after the sucrose challenge was also 
significantly less (Fig. 4). Area under the curve for the 
test group was 39.6% of control. When challenged 
directly with glucose (Fig 5), the circulating glucose 
levels after challenge in the test rats were similar to 
control with the exception of the fourth hour, when 
glucose levels were greater than control. Area under 
the curve for the test rats was 106.7% of control. When 
the rice starch and sucrose challenge were combined 
using the same concentrations that were given 
individually (Fig, 6), the appearance of circulating 
glucose over the first four hours was significantly 
lessened after gavage of the formula. The area under 
the curve for the test group was 49% of control. 
 
 
 
 
 
 
 
Fig. 2. The changes in systolic blood pressure (SBP) after daily 
challenges with water or two grams of the novel formulation 
dissolved in water is depicted. Mean + SEM shown for eight rats 
in each group. Rats drank a solution of 10% w/v sucrose in place 
of water from week 5 on. * Significantly different at that time 
point when compared to control. 
 
Fig. 3.  Both groups of eight rats that had received water 
(control) or water plus two grams of the formulation (test) daily 
for six-nine weeks underwent a similar regimen as described in 
reference 26. On the day of study, instead of the usual daily 
gavage, they were gavaged acutely with two grams of rice 
starch. One-half hour prior to the CHO challenges and at the 
time of challenges a total of four ml of water was given to 
control, or two gram of formulation in four ml water was given 
to the test group. The change in circulating glucose at timed 
intervals after various challenges is depicted. Mean + SEM 
shown for eight rats in each group. * Significantly different at 
that time point when compared to control. 
 
 
Fig. 4. Both groups of eight rats received a sucrose challenge. 
For details, see legend for Fig 3. Int. J. Med. Sci. 2007, 4 
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Fig. 5. Both groups of eight rats received a glucose challenge. 
For details, see legend for Fig 3. 
 
 
 
Blood chemistries obtained during the last week 
of study (Table 1) comparing the test rats with the 
controls showed a statistically significant decrease in 
circulating concentrations of glucose, sodium, and 
chloride. The 29% decrease compared to control in 
HbA1C missed statistical significance but showed a 
trend (p = 0.082). Circulating potassium and total 
protein concentrations increased significantly in the 
test group. No other differences existed for all other 
blood chemistries measured in control and treated rats 
[Table 1]. White blood cell count (WBC), red blood cell 
count (RBC), hemoglobin (HGB), hematocrit (HCT) 
and platelet count between the two groups were not 
significantly different.   
When the 24 hour intakes of food and water were 
examined at the end of studies (Fig 7), the mean daily 
food intake between groups was comparable -- 19.5 g + 
0.9 (SEM) (control) vs. 18.7 g +1.0 (SEM) (test). 
However, there was a statistically significant 
difference in daily water intake between the two 
groups - 116.0 ml + 3.1 (SEM) (control) vs. 63.1 ml + 5.8 
(SEM) (test) (p<0.0001).   
Table 1 Blood Chemistries for Carb-Ease Study 
Parameter Control Carb-Ease  p 
Glucose (mg/dl)  118.5+5.6  101.9+4.5  0.035* 
BUN (mg/dl)  19.3+0.9 17.6+0.4 0.125 
Creatinine (mg/dl) 
 
0.45+.02 
 
0.41+.01 
 
0.123 
 
Sodium (mEq/l) 
 
145+0.9 
 
141+0.9 
 
0.006* 
 
Potassium (mEq/l) 
 
4.3+0.2 
 
5.2+0.1 
 
0.001* 
 
Chloride (mEq/l) 
 
102.9+1.2 
 
98.8+1.1 
 
0.023* 
 
E CO2 (mEq/l) 
 
34.5+1.7 
 
37.4+1.2 
 
0.188 
 
Calcium (mg/dl) 
 
10.2+.02 
 
10.1+.03 
 
0.569 
 
T Chol (mg/dl) 
 
92.0+6.5 
 
87.6+4.2 
 
0.581 
 
Triglyc (mg/dl)  94.6+18.9 103.0+11.9 0.713 
 
T Protein (mg/dl)  6.9+0.12 7.3+0.08 0.012* 
 
Albumin (mg/dl) 
 
 
3.4+0.2 
 
 
3.5+0.07 
 
 
0.418 
 
AST (unit/dl) 
 
132.+10.0 
 
121.4+9.1 
 
0.410 
 
ALT (units/dl) 
 
46.9+4.6 
 
48.5+3.5 
 
0.779 
 
Alk Phos (mg/dl)  165+9.0 182+6.7 0.159 
T Bilirubin (mg/dl)  0.71+.09 0.84+.13   
0.441 
 
HbA1C  3.03+.34  2.34+.15  0.082# 
Average + SEM is shown 
* Statistically Significant; # Significant Trend   
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Fig. 6. Both groups of 8 rats received a combined rice starch (2 
grams)-sucrose (2 grams) challenge. For details, see figure 
legend for Fig 3. 
 
 
Fig 7. Twenty-four hour intake of food and water during the 
ninth week of the subchronic study. * Significantly different at 
that time point when compared to control. N=8 in the control [C] 
and test [T] groups. 
 
4.  DISCUSSION 
  Our previous studies show that a formulation 
composed of inhibitors of the gastrointestinal 
absorption of starch and sucrose were effective at 
lessening their absorption in rats and pigs [26]. To 
determine whether the CHO blocking effects persisted, 
rats were followed for nine weeks with daily gavages 
of a formula containing so called starch and sucrose 
blockers. Over this time period, we found no 
significant changes in the rate of body weight gain 
compared to control, although there was a tendency to 
see a lower gain in the group receiving the formula. 
Continuation of this study might have resulted in a 
significant difference. When the drinking water was 
changed to 10% w/v sucrose in week 5, the systolic 
blood pressure (SBP) of the control rats began to rise, 
whereas the SBP of the test rats showed no such 
elevation. In our experience, changes in the SBP are a 
very sensitive marker of insulin sensitivity, i.e., a rise 
in SBP correlates with the development of insulin 
resistance [27]. The prevention of the blood pressure 
elevation suggests that the CHO blockers overcame the 
induction of insulin resistance brought on by refined 
CHO.  
In the seventh through ninth week, the rats 
exposed daily to a combination of carb blockers 
received acute challenges of starch, sucrose and 
glucose in the same manner as the first acute studies 
[26]. After weeks of receiving the formula containing 
carb blockers, it was still able to lessen CHO 
absorption similar to that seen in the acute studies [26]. 
The utility of combining natural products containing 
inhibitors of both starch and sucrose absorption was 
strengthened when a combined starch-sucrose 
challenge, simulating a meal containing both, was 
influenced favorably by the novel formulation (Fig. 6).  
In the previous acute study [26], we had not seen 
any effects on circulating glucose levels in rats 
receiving only CHO blockers with no CHO challenge. 
These results suggested that the CHO inhibitors were 
not working on overall CHO metabolism. Findings in 
the present study corroborate that opinion. Unlike the 
challenges with rice starch and sucrose, glucose 
challenge was not affected by the formulation of 
natural products, suggesting little direct effect on 
exogenous glucose absorption or endogenous 
metabolism (Fig. 5) [28]. The latter finding in vivo again 
supports an effect of the natural products on the 
enzymes amylase and sucrase rather than on glucose 
absorption or metabolism  [29-37].  
 After nine weeks of daily intake of carb blockers, 
there was a significant lowering of circulating glucose 
levels in the test compared to the control rats. This 
finding is consistent with the trend to have lower 
circulating HbA1C levels in rats consuming carb 
blocking formulation. Perhaps only a trend was seen 
In HbA1C levels, because the time of imbibing the 
sucrose solution was not long enough to produce large 
differences in the latter measurement.  
The decrease in serum sodium and chloride 
concentrations coinciding with the increase in 
potassium levels suggests an effect of the formula on 
the renin-angiotensin-aldosterone system [38]. Because 
angiotensin 2 can influence water intake [39], a 
decrease in circulating angiotensin 2 might explain, at 
least in part, both the lower water intake and the 
decrease in SBP. Dietary CHO have long been known 
to influence hormonal systems such as the 
renin-angiotensin-aldosterone and catecholamine Int. J. Med. Sci. 2007, 4 
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systems [40,41]. 
These results support the hypothesis that CHO 
blockers like those examined in the present 
investigation will theoretically lower glycemic indices 
of various foods. Their activity continues even after 
weeks of constant intake. Further studies are needed to 
determine these ingredients will have a significant role 
in the therapy of various facets of the metabolic 
syndrome -- including the aging process.  
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